CELLECTIS - ADR (CLLS) Stock News

USA - NASDAQ:CLLS - US15117K1034 - ADR

3.29 USD

+0.01 (+0.3%)

Last: 11/5/2025, 11:32:50 AM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

CLLS Latest News, Press Relases and Analysis

All

Press Releases

20 days ago - By: Chartmill - Mentions: FOSL JBHT ANY ADAP ...

News Image

Thursday's session: gap up and gap down stocks

20 days ago - By: Chartmill - Mentions: FOSL AIV ADAP AEHL ...

News Image

Stay updated with the stocks that are on the move in today's pre-market session.

2 days ago - By: Cellectis Inc.

Cellectis to Present a Development Update for eti-cel at ASH 2025

2 days ago - By: Cellectis Inc.

Cellectis to Present a Development Update for eti-cel at ASH 2025

2 days ago - By: Cellectis Inc.

Cellectis présentera de nouvelles avancées sur éti-cel lors du congrès annuel de l’ASH 2025

5 days ago - By: Cellectis Inc.

Cellectis to Report Third Quarter Financial Results on November 7, 2025

5 days ago - By: Cellectis Inc.

Cellectis to Report Third Quarter Financial Results on November 7, 2025

5 days ago - By: Cellectis Inc.

Cellectis publiera ses résultats financiers du troisième trimestre le 7 novembre 2025

16 days ago - By: Benzinga - Mentions: EXEL CCM GMAB ADXN ...

Olema Pharmaceuticals, Exelixis, Genmab And Other Big Stocks Moving Lower In Monday's Pre-Market Session

20 days ago - By: Cellectis Inc.

Cellectis’ R&D Day Highlights Lasme-cel’s Potential to Address Significant Unmet Need for Patients with r/r B-ALL

20 days ago - By: Cellectis Inc.

Cellectis’ R&D Day Highlights Lasme-cel’s Potential to Address Significant Unmet Need for Patients with r/r B-ALL

20 days ago - By: Cellectis Inc.

Le R&D Day de Cellectis souligne le potentiel de lasmé-cel pour combler un besoin médical majeur non satisfait chez les patients atteints de LAL-B en rechute ou réfractaire

20 days ago - By: Benzinga - Mentions: DDD SLI JBHT CRM ...

Enerpac Tool Group Posts Upbeat Results, Joins Praxis Precision Medicines, J B Hunt, Salesforce And Other Big Stocks Moving Higher On Thursday

20 days ago - By: Cellectis Inc.

Cellectis Hosts R&D Day Today Showcasing Pipeline Progress and Long-Term Value Drivers

20 days ago - By: Cellectis Inc.

Cellectis Hosts R&D Day Today Showcasing Pipeline Progress and Long-Term Value Drivers

20 days ago - By: Cellectis Inc.

Cellectis organise aujourd’hui son R&D Day pour présenter les avancées de son portefeuille et ses perspectives à long terme

a month ago - By: Cellectis Inc.

Monthly information on share capital and company voting rights

a month ago - By: Cellectis Inc.

Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

a month ago - By: Cellectis Inc.

Cellectis to Present Data on Non-Viral Gene Therapy and TALE Base Editors at the ESGCT Annual Congress

a month ago - By: Cellectis Inc.

Cellectis to Present Data on Non-Viral Gene Therapy and TALE Base Editors at the ESGCT Annual Congress

a month ago - By: Cellectis Inc.

Cellectis présentera des données sur son programme de thérapie génique non-virale et sur des TALE Base Editors lors du congrès annuel de l’ESGCT

2 months ago - By: Cellectis Inc.

Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

2 months ago - By: Cellectis Inc.

Monthly information on share capital and company voting rights

3 months ago - By: Cellectis Inc.

Monthly information on share capital and company voting rights

3 months ago - By: Cellectis Inc.

Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

3 months ago - By: Cellectis Inc.

Cellectis Reports Second Quarter 2025 Financial Results & Business Updates

3 months ago - By: Cellectis Inc.

Cellectis publie ses résultats financiers du deuxième trimestre 2025 et une mise à jour de ses activités

3 months ago - By: Cellectis Inc.

Cellectis Reports Second Quarter 2025 Financial Results & Business Updates

3 months ago - By: Cellectis Inc.

Cellectis to Report Second Quarter 2025 Financial Results on August 4, 2025

3 months ago - By: Cellectis Inc.

Cellectis to Report Second Quarter 2025 Financial Results on August 4, 2025

3 months ago - By: Cellectis Inc.

Cellectis publiera ses résultats financiers du deuxième trimestre 2025 le 4 août 2025